LIRAGLUTIDE | A214568 | TEVA PHARMACEUTICALS DEVELOPMENT INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Novo Nordisk Inc. et al v. Teva Pharmaceuticals, Inc. et al 17 patentsANDA 214568liraglutide recombinant | D. Del. | 2021-12-21 | Terminated 2023-09-25 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Code | Date | Status |
|---|---|---|
| PC | Feb 24, 2026 | Expired |